About |
RNatives is a biotechnology company developing precision RNA-based gene regulating therapies by leveraging its RNAIntelTM platform which identifies small non-coding RNAs that bind directly to gene promoters to regulate gene expression. The Company is developing novel RNA-based therapies to treat ocular, CNS, and metabolic diseases, as well as cancer. For more information, visit www.rnatives.com.